Unlock Your Company’s
GROWTH Potential
Lead Your Company to the Next Level with Our Proven Innovation Methodology
Embrace Change, Leverage Untapped Resources,
and Drive Transformative Growth
Catalyst for Growth for C-suite Executives

Self-Awareness

The Innovation Superpowers

The Physics of Innovation

Overcoming the Corporate Antibodies

The 4C's Framework

Storytelling

Meet Tom
I engage C-Suite executives and emerging leaders to serve as a catalyst to drive business growth while accelerating the development of high-impact leaders. I work with a number of life science, CPG, and technology companies to help identify step-change growth opportunities—typically at the intersection of technology and business strategy. I fuel my curiosity about, and passion for emerging technologies as an advisor to a number of early stage technology, life science and health tech businesses.
I taught courses on venture initiation and entrepreneurial marketing at Wharton’s SBDC and at Villanova’s School of Business, authored a book on innovation, delivered a TEDx on “The Power of Inexperience,” and was the featured guest on a Technology and Business Transformation podcast.
I understand what it takes to stand-up and grow new businesses having spent almost 2 decades as a corporate executive at J&J and GSK, navigating the labyrinth of approvals, and overcoming the corporate antibodies that come out to kill new initiatives (and the people driving them). I have the unique ability to be an “outside” advisor/expert on entrepreneurship and start-up/small business growth strategies with an “inside” understanding of what it takes to drive corporate growth initiatives.

The TBI Way
Challenge the status quo
Identify transformative growth opportunities
Co-create solutions with customers
Build organizational momentum
Embrace "failure" as a stepping stone to success
Establish "action inertia"
Entrusted to Grow Businesses
Created Point-of-Care Diagnostics Business Unit in Clinical Labs Division
Recommendation to buy Millstone while on Folgers Brand
COO of medicinal cannabis business acquired for $225M
